FHDH-ANRS CO4 Cohort: HCV Incidence in MSM With HIV Declined Following Access to HCV DAA Therapy in France

March 8-11, 2020; Boston, Massachusetts
HCV incidence in MSM with HIV in France declined from 2014 to 2017 following unrestricted access of HCV DAA therapy for persons with HIV.
Format: Microsoft PowerPoint (.ppt)
File Size: 156 KB
Released: March 17, 2020

Acknowledgements

Provided by USF Health, in partnership with Clinical Care Options, LLC

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd

This activity is supported by educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Download free expert-authored slides reviewing a patient case and the relevant data and guidance on HIV/HBV coinfection in older patients

Jürgen K. Rockstroh, MD Released: October 20, 2020

Expert commentary on COVID-19 risk in persons with HIV and the best strategies to minimize risk

Renslow Sherer, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: October 12, 2020 Expired: October 11, 2021

Expert-authored CCO slides on the impact of HIV infection on COVID-19 risk and disease severity and the impact of COVID-19 on access to HIV care

W. David Hardy, MD
Program Director
Monica Gandhi, MD, MPH
Released: September 25, 2020

Expert commentary from CCO on experiences integrating telehealth to retain unsuppressed patients with HIV in care during the COVID-19 pandemic

David A. Wohl, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: August 14, 2020 Expired: August 13, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue